Skip to search.
 TSX Down 0.45% TSX Ventures Down 0.59%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
11.32 Up 0.10(0.89%) 1:01PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:11.22
Open:10.91
Bid:11.37 x 600
Ask:11.38 x 500
1y Target Est:13.25
Beta:0.71
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:10.67 - 11.59
52wk Range:2.31 - 14.40
Volume:1,525,686
Avg Vol (3m):3,633,200
Market Cap:1.45B
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ZIOPUp 0.89%1.45B
IMGNUp 1.71%1.23B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):994.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.70
Quarterly EPS Est (Jun-15) :-0.22
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback